Newsroom
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
Media Center
Media
CRISPR-Based ALS Treatment Being Developed by Scribe and Biogen
October 9, 2020
Genetic Engineering & Biotechnology News
Read Now
Press Release
CRISPR-Based ALS Treatment Being Developed by Scribe and Biogen
October 9, 2020
Genetic Engineering & Biotechnology News
Read Now
Media
Biogen teams up with gene-editing startup Scribe on ALS programme
October 8, 2020
Pharma Phorum
Read Now
Press Release
Biogen teams up with gene-editing startup Scribe on ALS programme
October 8, 2020
Pharma Phorum
Read Now
Media
Doudna Spin Out Scribe, Partners with Biogen on CRISPR-Based Treatment for ALS
October 8, 2020
Inside Precision Medicine
Read Now
Press Release
Doudna Spin Out Scribe, Partners with Biogen on CRISPR-Based Treatment for ALS
October 8, 2020
Inside Precision Medicine
Read Now
Media
Scribe, Biogen Partner to Develop Gene Therapy for ALS, Other Neurological Diseases
October 8, 2020
ALS News Today
Read Now
Press Release
Scribe, Biogen Partner to Develop Gene Therapy for ALS, Other Neurological Diseases
October 8, 2020
ALS News Today
Read Now